2-(Arylamino)thiazol-4(5H)-ones Mitigate Oxidative Stress and Confer Neuroprotection in Cellular and Drosophila Models of Alzheimer’s Disease
International Journal of Molecular Sciences · 25.07.2026 · 27 (15) · 6642
DOI: 10.3390/ijms27156642 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.07.2026. Verfasst von Nikhil Raj Selvaraj und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, India. Hauptthemen laut MEDLINE: Oxidative Stress, Alzheimer Disease, Neuroprotective Agents, Thiazoles. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Provost, Amrita Vishwa Vidyapeetham.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a complex neurodegenerative disorder with limited effective therapies. In this study, a series of 2-(arylamino)thiazol-4(5H)-one derivatives was synthesized using an efficient microwave-assisted protocol, and evaluated for neuroprotective effects against 6-hydroxydopamine (6-OHDA)-induced oxidative stress (OS) in SH-SY5Y neuronal cells and an Aβ42-expressing Drosophila melanogaster model of AD. Among the synthesized compounds, 3n, 3i, and 3b exhibited low cytotoxicity and significant neuroprotection, as evidenced by increased cell viability, reduced reactive oxygen species (ROS) production, and preserved mitochondrial membrane potential. Notably, compound 3n demonstrated the highest activity and effectively ameliorated Aβ42-induced behavioral deficits in vivo. Molecular docking studies predicted favorable binding affinity within the acetylcholinesterase (AChE) active site, with the thiazol scaffold and aryl substituents stabilizing ligand binding through π–π stacking and hydrophobic interactions; compound 3n also formed additional hydrogen bonds enhancing its affinity. Consistent with the docking predictions, in vitro AChE inhibition studies demonstrated that compounds 3n, 3i, and 3b inhibited AChE in a concentration-dependent manner. Network pharmacology predicted seven potential core targets implicated in AD pathogenesis and related pathways, including OS, neuroinflammation, and synaptic dysfunction. Furthermore, in silico pharmacokinetic analysis indicated compliance with Lipinski’s and Veber’s rules, supporting favorable drug-like properties. While further experimental validation is essential, these findings highlight 2-(arylamino)thiazol-4(5H)-one derivatives, particularly compound 3n, as promising multifunctional candidates for further preclinical development against AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, India.
- Department of Chemistry, REVA University, Kattigenahalli, Yelahanka, Bangalore 560064, India.
ORCID-Profile: Durga Nandan, Sudarslal Sadasivan Nair
Förderung
- Provost, Amrita Vishwa Vidyapeetham
Zitieren
APA
Selvaraj, N. R., V, B. S., Nandan, D., San, S., Nair, S. S., Nair, B. G., Venugopal, P., Aradhya, R., & Nair, V. A. (2026). 2-(Arylamino)thiazol-4(5H)-ones Mitigate Oxidative Stress and Confer Neuroprotection in Cellular and Drosophila Models of Alzheimer’s Disease. International Journal of Molecular Sciences, 27(15), 6642. https://doi.org/10.3390/ijms27156642
Vancouver
Selvaraj NR, V BS, Nandan D, San S, Nair SS, Nair BG, et al. 2-(Arylamino)thiazol-4(5H)-ones Mitigate Oxidative Stress and Confer Neuroprotection in Cellular and Drosophila Models of Alzheimer’s Disease. International Journal of Molecular Sciences. 2026;27(15):6642. doi:10.3390/ijms27156642
BibTeX
@article{Selvaraj2026,
author = {Selvaraj, Nikhil Raj and V, Bhuvaneshwari S and Nandan, Durga and San, Sandra and Nair, Sudarslal Sadasivan and Nair, Bipin G and Venugopal, Parvathy and Aradhya, Rajaguru and Nair, Vipin A},
title = {2-(Arylamino)thiazol-4(5H)-ones Mitigate Oxidative Stress and Confer Neuroprotection in Cellular and Drosophila Models of Alzheimer’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6642},
doi = {10.3390/ijms27156642}
}
EUVIMED